Understanding MRD: Insights for clinical practice and patient care
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
Understanding MRD: Insights for clinical practice and patient care
-
Narrado por:
-
De:
Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA
Recorded on September 25, 2025
Rahul Banerjee, MD, FACP
Assistant Professor
Fred Hutchinson Cancer Center
Seattle, WA
In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores what MRD is, how assays are used and interpreted, and its impact across the disease continuum. The conversation also covers MRD’s role in clinical trials, how to effectively explain MRD to patients, practical considerations for testing in community settings, and key education resources for both healthcare professionals and patients. Tune in today to gain practical insights you can apply in your daily practice!
This episode is supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.
Todavía no hay opiniones